America's Most Talked-About Drug Has a Surprising Secret: 69% of GLP-1 Users Are Unlikely to Admit Taking It
While Americans are talking about weight-loss drugs more than ever, a national survey finds less than a third would openly admit to using one
Virta Health, the leader in metabolic disease reversal, today released its third annual 2026 Virta Vitals, a national survey of U.S. adults that examines Americans' evolving attitudes and behaviors toward GLP-1 medications. While GLP-1 medications have become one of the most visible health trends in America, this year’s report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one, revealing a surprising gap between public conversation and personal disclosure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615373875/en/
Over the past two years, GLP-1s have become a common topic of discussion far beyond clinical settings. The number of Americans who personally know someone who has used a GLP-1 for weight loss has increased by double digits in two years (from 21%1 to 31%), and nearly half (48%) now view these medications primarily as a weight-loss tool or lifestyle drug rather than as a treatment for chronic disease.
